- 1、本文档共10页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
周剂量多西紫杉醇联合顺铂及氟尿嘧啶治疗晚期胃癌疗效观察
周剂量多西紫杉醇联合顺铂及氟尿嘧啶治疗晚期胃癌疗效观察[摘要] 目的 探讨周剂量多西紫杉醇联合顺铂及氟尿嘧啶治疗晚期胃癌的疗效。 方法 将本院收治的98例晚期胃癌患者随机分为观察组与对照组,各49例,观察组给予周剂量多西紫杉醇联合顺铂及氟尿嘧啶方案进行治疗,对照组给予奥沙利铂联合亚叶酸钙及替加氟方案进行治疗,比较两组患者的疗效及副作用等。结果 观察组的有效率为63.3%,与对照组的42.9%比较,差异有统计学意义(χ2 = 4.097,P < 0.05)。两组患者的主要副作用经统计学比较,差异无统计学意义(均P > 0.05)。与治疗前比较,两组患者治疗后生活质量评分均有所提高,但是两组间生活质量评分比较差异无统计学意义。结论 周剂量多西紫杉醇联合顺铂及氟尿嘧啶治疗晚期胃癌疗效显著,值得临床进一步证实推广。
[关键词] 多西紫杉醇;顺铂;氟尿嘧啶;晚期胃癌
[中图分类号] R573.1 [文献标识码] A [文章编号] 1673-7210(2012)01(b)-089-02
Clinical observation of Docetaxel of weekly doses combined with Cisplatin and Fluorouracil in the treatment of advanced gastric cancer
ZENG Hu CAI Maode ZHONG Liang
The First Department of Cancer Chemotherapy, the People′s Hospital of Gaozhou City, Guangdong Province, Gaozhou 525200, China
[Abstract] Objective To study the curative effect of Docetaxel of weekly doses combined with Cisplatin and Fluorouracil in the treatment of advanced gastric cancer. Methods 98 cases of patients with advanced gastric cancer were randomly divided into observation group and control group, each group of 49 cases, the observation group was given Docetaxel of weekly doses combined with Cisplatin and Fluorouracil, and the control group was given Oxaliplatin combined with Folic Acid Calcium and Fluoridated, the effect and side reactions of patients between the two groups were compared. Results The effective rate of observation group was 63.3%, compared with 42.9% in the control group, the difference was statistically significant (χ2 = 4.097, P < 0.05). The differences of major adverse reactions between the two groups were no statistically significant (all P > 0.05). Compared with treatment before, the quality of life scores of the two groups after treatment were all improved, but the quality of life scores between the two groups were no significant. Conclusion Docetaxel of weekly doses combination with Cisplatin and Fluorouracil in the treatment of advanced gastric cancer has a distinct curative effect, which is worthy of further confi
文档评论(0)